ESC 365 - A pooled health-economic analysis of DAPA-HF and DELIVER: A French cost-effectiveness analysis of dapagliflozin for the treatment of patients with heart failure

HFA Premium Access

A pooled health-economic analysis of DAPA-HF and DELIVER: A French cost-effectiveness analysis of dapagliflozin for the treatment of patients with heart failure

Session: Chronic heart failure - treatment 4

Topic: Treatment

Speaker: Doctor J. Chen (Gaithersburg, US)

Event: Heart Failure 2023

Congress Presentation

Add to my library

About the speaker

Doctor Jieling Chen

AstraZeneca BioPharmaceuticals, Gaithersburg (United States of America)

1 presentation

0 follower

3 more presentations in this session

Role of dietary sodium restriction in chronic HF - systematic review and meta-analysis.

Speaker: Doctor S. Urban (Lubin, PL)

A multicentre survey of cardiologists nutritional assessment and education for patients hospitalised with heart failure

Speaker: Doctor T. Dotare (Tokyo, JP)

Long-term outcomes for an endovascular carotid implant approach for HFrEF

Speaker: Professor M. Rothman (Irvine, US)

Access the full session

Chronic heart failure - treatment 4

Speakers: Doctor J. Chen, Doctor S. Urban, Doctor T. Dotare, Professor M. Rothman

About the event

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources